STAT
JUNE 9, 2025
Health secretary Robert F. Kennedy Jr. has taken the extraordinary step of firing the expert panel that advises the Centers for Disease Control and Prevention, saying the action is needed to restore faith in vaccines. “A clean sweep is needed to re-establish public confidence in vaccine science,” Kennedy said in an op-ed published Monday afternoon in the Wall Street Journal.
PharmaVoice
JUNE 9, 2025
Skip to main content CONTINUE TO SITE ➞ Dont miss the most important voices in pharma Let PharmaVoices free newsletter keep you informed on what industry leaders are saying, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Deve
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JUNE 9, 2025
The National Institutes of Health has, for now, walked back a policy requiring universities and other research institutes to certify that they do not have unlawful diversity, equity, and inclusion programs or boycotts of Israel in order to receive research dollars. The rule, which was initially posted in April , was seen as the next stage of using research funds as leverage against private universities and efforts to increase diversity in the sciences.
Pharmaceutical Business Review
JUNE 9, 2025
Duvyzat must be administered alongside corticosteroids and is not limited by the patient’s specific genetic mutation. The decision is applicable across all 27 EU member states, as well as Iceland, Liechtenstein, and Norway. Following a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) in April 2025, this approval marks a significant milestone.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
STAT
JUNE 9, 2025
The Make America Healthy Again movement has a lot of the food industry on edge. Health secretary Robert F. Kennedy Jr. and his allies have made concerns about the health effects of ultra-processed foods a government priority , putting titans like PepsiCo, Kraft Heinz, and Nestlé on the defensive. But for a smaller contingent of food companies with products that align with MAHA’s vision of what a healthy diet looks like — from organic produce to emulsifier-free chocolates
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
STAT
JUNE 9, 2025
Metsera’s obesity drug candidate targeting the amylin hormone showed marked efficacy in an early trial and the potential to have longer-lasting effects than current weight loss treatments on the market that are injected weekly. In one part of a Phase 1 trial where patients received a single dose, those on the highest dose of 2.4 milligrams experienced an average of 5.3% placebo-adjusted weight loss at one week, the company said Monday.
Drug Patent Watch
JUNE 9, 2025
"Navigating the Maze of Regulations: How Pharmaceutical Companies Can Safeguard Their Drug Portfolios As the pharmaceutical industry continues to evolve, regulatory environments are becoming increasingly complex. With new laws and guidelines emerging regularly, companies must stay agile to avoid costly delays and maintain market competitiveness.
STAT
JUNE 9, 2025
As a researcher and medical device designer, I’ve spent years immersed in pediatric hospitals and homes, observing and listening. One moment from my recent research still keeps me up at night. A mother described how her toddler stopped breathing one afternoon at home. Instead of calling 911, she grabbed a faulty suction machine, the only one Medicaid had provided and prayed it would keep working long enough to clear her son’s airway.
Express Pharma
JUNE 9, 2025
The Confederation of Indian Industry (CII), Telangana, has announced the “Pillars of Protection – Forging a Safer Future for Pharma and Chemical Manufacturing” conference, which is scheduled to take place on 25th June 2025 in Hyderabad. The event is positioned as a strategic forum for stakeholders across the pharmaceutical and chemical sectors, including industry leaders, regulators, safety experts, and operational heads.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
JUNE 9, 2025
This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here. Hello, everyone! Welcome back. If you sign up for an annual STAT+ subscription in the next week, you’ll get 50% off. Appreciate all of you who choose to read us in any capacity— especially you HCI subscribers. Hit me up with your tips and summer plans: bob.herman@statnews.com.
Express Pharma
JUNE 9, 2025
OneSource Specialty Pharma, a contract development and manufacturing organisation (CDMO) focused on multi-modality drug products, announced that its flagship facility in Bangalore, India, has maintained compliance with United States Food and Drug Administration (USFDA) regulations following a recent inspection. The inspection, conducted from 20 March to 28 March 2025, concluded with the issuance of a Form 483 that included four observations.
STAT
JUNE 9, 2025
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. And another week begins — I kind of cannot believe that we’re already nearing “mid” June. If you’re feeling particularly appreciative of STAT’s reporting this summer, you can use code JUNE50 to save 50% off a STAT+ annual subscription.
pharmaphorum
JUNE 9, 2025
Otsuka and Vera both have new phase 3 data on drugs for kidney disease IgA nephropathy, but can they make a mark in an increasingly crowded market
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
STAT
JUNE 9, 2025
National Resilience, a startup that has raised over $2 billion by promising to transform drug manufacturing, said Monday that it would “wind down” many of its facilities. But what remains of the firm has raised an additional $250 million from existing investors to continue to build its business and seek more capital. Through a bit of financial engineering, an affiliate of the firm that holds leases for six of the company’s manufacturing facilities is filing for b
Pharma Times
JUNE 9, 2025
Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs PharmaTimes Clinical Researcher of the Year – The Americas by John Pinching | 9th Jun 2025 | News Enter The 2025 PharmaTimes Clinical Researcher of the Year – The Americas!
STAT
JUNE 9, 2025
Avidity Biosciences reached an agreement with the Food and Drug Administration to seek accelerated approval of a new treatment for an inherited muscle-weakening disease, the company said Monday. The FDA’s willingness to consider an early approval for the Avidity drug should further assuage concerns from the biotech industry and investors about the agency’s stance on rare disease therapies in the face of staffing cuts and new leadership.
pharmaphorum
JUNE 9, 2025
The NHS is said to be in line for a £30bn increase to its budget in the upcoming spending review, but some are concerned it will not be enough
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Pharmaceutical Technology
JUNE 9, 2025
The EC has granted approval for a fixed-duration regimen of AstraZeneca's Calquence (acalabrutinib) plus venetoclax.
The Pharmacist
JUNE 9, 2025
The Medicines and Healthcare Regulatory Authority (MHRA) has recalled specific batches of Paracetamol 500mg Tablets (Chelonia Healthcare Limited) as a precautionary measure, ‘due to contamination’. The move follows a small number of complaints of discoloured tablets within some packs, reported by healthcare professionals. In a class 2 medicines notification issues today, Chelonia Healthcare Limited has […] The post Two batches of paracetamol recalled due to ‘contamination’ appeared first o
Pharmafile
JUNE 9, 2025
Vertex Pharmaceuticals has presented new data showing the clinical and quality-of-life benefits of its cystic fibrosis (CF) therapies, particularly Alyftrek (deutivacaftor/tezacaftor/vanzacaftor). The findings, shared at the 48th European Cystic Fibrosis Conference, 4 to 7 June 2025, Milan, Italy, highlight the potential of CF transmembrane conductance regulator (CFTR) modulators to significantly improve patient outcomes.
pharmaphorum
JUNE 9, 2025
As an FDA decision nears from a rival MSD drug, Sanofi is speeding up the rollout of RSV antibody Beyfortus to get ahead of this year's season
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Pharmafile
JUNE 9, 2025
Elgan Pharma, specialising in neonatology, and Italy-based biopharma, Chiesi Farmaceutici, have announced the dosing of the first participating infants in FIT-PIV, a phase 3 clinical study of ELGN-2112, a prospective treatment for intestinal malabsorption in preterm infants. The FIT-PIV study is expected to roll 420 infants, born 26-32 weeks and weighing at least 500g, at […] The post Study into treatment for rare condition in premature infants launches globally appeared first on Pharmafil
European Pharmaceutical Review
JUNE 9, 2025
The UK Government is set to announce an investment of £86 billion in next week’s Spending Review, aimed at boosting the country’s highest growth sectors, such as life sciences. The review will specify how the government is planning to invest in Britain’s renewal, which helps to drive its Plan for Change. This commitment will support a broad range of sectors, including advanced manufacturing.
Pharmafile
JUNE 9, 2025
21GRAMS and Havas Lynx lead the charge at the PM Society Awards for pharma marketing and healthcare communications Commenting on behalf of the judges, Carrie Kenyon from Finger Industries said: “With an important objective, to guide doctors to a realisation that they may be practising outdated medicine in treating hyperkalaemia, the film itself was brilliantly […] The post The unbearable lightness of creativity appeared first on Pharmafile.
Pharmaceutical Technology
JUNE 9, 2025
Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Expert insights. Personalized for you.
364 
Let's personalize your content